$4.87
0.12.10%
At Close: -
$4.41
-0.46-9.45%
After Hours: 6:02 PM EDT
15 minutes delayed
Comments
Loading...
Edesa Biotech
EDSANASDAQ
Edesa Biotech (NASDAQ:EDSA) Stock, Insider Trading Activity
Edesa Biotech: Insider buying and selling updated today.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Edesa Biotech Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for Edesa Biotech Inc
Institutional Shares Held
34.246K
Institutional Percentage Held
1.05%
| Mar 25, 2024 | Pardeep NijhawanPardeep Nijhawan Medicine Professional Corp | CHIEF EXECUTIVE OFFICER | 5.00K | $4.00 | $20.00K | BUY | 1.28% | 394.81K | Mar 25 | View |
| Jan 11, 2023 | Peter Velden der vanLumira Capital Investment Management Inc | 10% OWNER | -297.47K | $2.65 | -$787.72K | SELL | -66.44% | 150.28K | Jan 09 - Jan 10 | View |
| Jul 05, 2022 | Pardeep NijhawanPardeep Nijhawan Medicine Professional Corp | CHIEF EXECUTIVE OFFICER | 20.00K | $1.60 | $32.08K | BUY | 2.11% | 966.54K | Jun 30 | View |
| Jun 30, 2022 | Michael J Brooks | PRESIDENT | 3.00K | $1.49 | $4.48K | BUY | 12.91% | 26.24K | Jun 29 | View |
| Jun 21, 2022 | Michael J Brooks | PRESIDENT | 3.00K | $1.61 | $4.82K | BUY | 14.82% | 23.24K | Jun 16 | View |
| May 31, 2022 | Pardeep NijhawanPardeep Nijhawan Medicine Professional Corp | CHIEF EXECUTIVE OFFICER | 5.00K | $1.92 | $9.60K | BUY | 0.53% | 946.54K | May 27 | View |
| May 26, 2022 | Michael J Brooks | PRESIDENT | 3.50K | $1.74 | $6.09K | BUY | 20.91% | 20.24K | May 25 | View |
| May 25, 2022 | Pardeep NijhawanPardeep Nijhawan Medicine Professional Corp | CHIEF EXECUTIVE OFFICER | 2.00K | $1.80 | $3.60K | BUY | 0.21% | 941.54K | May 24 | View |
| Apr 01, 2022 | Pardeep NijhawanPardeep Nijhawan Medicine Professional Corp | CHIEF EXECUTIVE OFFICER | 2.00K | $2.99 | $5.97K | BUY | 0.21% | 939.54K | Mar 31 | View |
| Mar 31, 2022 | Pardeep NijhawanPardeep Nijhawan Medicine Professional Corp | CHIEF EXECUTIVE OFFICER | 2.00K | $3.05 | $6.10K | BUY | 0.21% | 937.54K | Mar 30 | View |
| Mar 30, 2022 | Pardeep NijhawanPardeep Nijhawan Medicine Professional Corp | CHIEF EXECUTIVE OFFICER | 2.00K | $3.02 | $6.03K | BUY | 0.21% | 935.54K | Mar 29 | View |
| Mar 21, 2022 | Pardeep NijhawanPardeep Nijhawan Medicine Professional Corp | CHIEF EXECUTIVE OFFICER | 2.00K | $3.85 | $7.70K | BUY | 0.21% | 933.54K | Mar 18 | View |
| Mar 18, 2022 | Pardeep NijhawanPardeep Nijhawan Medicine Professional Corp | CHIEF EXECUTIVE OFFICER | 2.00K | $3.26 | $6.52K | BUY | 0.22% | 931.54K | Mar 17 | View |
| Mar 16, 2022 | Pardeep NijhawanPardeep Nijhawan Medicine Professional Corp | CHIEF EXECUTIVE OFFICER | 2.00K | $2.80 | $5.60K | BUY | 0.22% | 929.54K | Mar 15 | View |
| Mar 15, 2022 | Michael J Brooks | PRESIDENT | 1.25K | $2.79 | $3.49K | BUY | 8.07% | 16.74K | Mar 14 | View |
| Mar 14, 2022 | Pardeep NijhawanPardeep Nijhawan Medicine Professional Corp | CHIEF EXECUTIVE OFFICER | 7.00K | $3.09 | $21.65K | BUY | 0.76% | 927.54K | Mar 11 | View |
| Mar 11, 2022 | Michael J Brooks | PRESIDENT | 1.00K | $3.22 | $3.22K | BUY | 6.90% | 15.49K | Mar 10 | View |
| Mar 10, 2022 | Pardeep NijhawanPardeep Nijhawan Medicine Professional Corp | CHIEF EXECUTIVE OFFICER | 1.50K | $3.05 | $4.57K | BUY | 0.16% | 920.54K | Mar 09 | View |
| Mar 09, 2022 | Michael J Brooks | PRESIDENT | 1.25K | $2.90 | $3.62K | BUY | 9.44% | 14.49K | Mar 08 | View |
| Mar 29, 2021 | Pardeep NijhawanPardeep Nijhawan Medicine Professional Corp | CHIEF EXECUTIVE OFFICER | 2.00K | $5.23 | $10.46K | BUY | 0.22% | 919.04K | Mar 29 | View |
| Mar 26, 2021 | Pardeep NijhawanPardeep Nijhawan Medicine Professional Corp | CHIEF EXECUTIVE OFFICER | 3.00K | $5.25 | $15.75K | BUY | 0.33% | 917.04K | Mar 25 | View |
| Mar 26, 2021 | Michael J Brooks | PRESIDENT | 3.50K | $5.19 | $18.16K | BUY | 35.93% | 13.24K | Mar 25 | View |
| Mar 25, 2021 | Michael J Brooks | PRESIDENT | 4.50K | $5.08 | $22.86K | BUY | 85.86% | 9.74K | Mar 24 | View |
| Mar 25, 2021 | Pardeep NijhawanPardeep Nijhawan Medicine Professional Corp | CHIEF EXECUTIVE OFFICER | 5.00K | $5.16 | $25.80K | BUY | 0.55% | 914.04K | Mar 24 | View |
| Feb 18, 2021 | Frank R Oakes | — | -7.99K | $7.25 | -$57.94K | SELL | -100.00% | 0.00 | Feb 18 | View |
| May 29, 2020 | Michael J Brooks | — | 2.50K | $3.00 | $7.50K | PURCHASE | 136.84% | 4.33K | May 27 | View |
| May 28, 2020 | Pardeep NijhawanPardeep Nijhawan Medicine Professional Corp | — | 3.00K | $2.98 | $8.94K | PURCHASE | 0.11% | 2.66M | May 26 | View |
| Mar 19, 2020 | Pardeep NijhawanPardeep Nijhawan Medicine Professional Corp | — | 5.00K | $1.87 | $9.37K | PURCHASE | 0.21% | 2.35M | Mar 17 | View |
| Jan 10, 2020 | Peter Velden der vanLumira Capital Investment Management Inc | — | 140.63K | $3.20 | $450.00K | PURCHASE | 486.98% | 169.50K | Jan 08 | View |
| Jan 10, 2020 | Carlo Sistilli | — | 2.44K | $4.11 | $10.01K | PURCHASE | ∞ | 2.44K | Jan 08 | View |
| Jan 10, 2020 | Lorin K Johnson | — | 8.52K | $4.11 | $35.03K | PURCHASE | ∞ | 8.52K | Jan 08 | View |
| Jan 10, 2020 | Michael J Brooks | — | 1.83K | $4.11 | $7.51K | PURCHASE | ∞ | 1.83K | Jan 08 | View |
| Sep 13, 2019 | Frank R Oakes | — | -1.81K | $5.72 | -$10.35K | SELL | -22.69% | 6.17K | Sep 11 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.